-
DE
Decompressive craniectomy is a neurosurgical procedure in which part of the skull is removed to relieve life-threatening increases in intracranial pressure.
Decompressive craniectomy is a neurosurgical procedure in which part of the skull is removed to relieve life-threatening increases in intracranial pressure.
Decompressive craniectomy is an emergency neurosurgical procedure in which a portion of the skull bone is temporarily removed. The goal is to give the swelling brain more space and thereby reduce dangerously elevated intracranial pressure (ICP). Because the skull forms a rigid bony enclosure, swelling brain tissue has nowhere to expand – without intervention, this leads to severe brain damage or death.
The procedure is used when other measures to reduce pressure – such as medications, patient positioning, or mechanical ventilation – are insufficient. Common indications include:
The operation is performed under general anesthesia. The neurosurgeon makes an incision in the scalp and removes a bone flap typically measuring 10–15 cm in diameter. The underlying membrane covering the brain (dura mater) is also opened or expanded (duraplasty) to create additional space. The removed bone fragment is stored under sterile conditions – either refrigerated or implanted in the subcutaneous tissue of the abdomen – until it is reinserted in a second procedure (cranioplasty) after the patient has recovered.
In most cases, a unilateral (one-sided) craniectomy is performed, for example in malignant MCA infarction. In cases of diffuse brain injury following severe TBI, a bilateral craniectomy may be required.
Until the bone is reinserted, the area of the skull defect must be protected with a specially designed helmet. Cranioplasty – surgical closure of the skull defect – is typically performed 6 weeks to 3 months after the craniectomy, once the patient has stabilized. Either the patient's own bone or an implant made of titanium or synthetic material is used.
Like any surgical procedure, decompressive craniectomy carries risks:
The evidence base for decompressive craniectomy is nuanced. For malignant MCA infarction, several randomized controlled trials (including DESTINY II) have shown that the procedure significantly reduces mortality. However, more surviving patients may live with severe disability. In severe traumatic brain injury (DECRA and RESCUEicp trials), craniectomy also reduces mortality but increases the proportion of patients in a vegetative state. The decision to perform this procedure therefore requires careful individual consideration and ethical counseling.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.